{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:24:26Z","timestamp":1793381066964,"version":"4.5.0"},"reference-count":193,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>European guidelines on cardiovascular prevention in clinical practice were first published in 1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint Task Force. Given the amount of new information that has become available since then, components from the task force and experts from the European Association of Preventive Cardiology of the European Society of Cardiology were invited to provide a summary and critical review of the most important new studies and evidence since the latest guidelines were published. The structure of the document follows that of the previous document and has six parts: Introduction (epidemiology and cost effectiveness); Cardiovascular risk; How to intervene at the population level; How to intervene at the individual level; Disease-specific interventions; and Settings: where to intervene? In fact, in keeping with the guidelines, greater emphasis has been put on a population-based approach and on disease-specific interventions, avoiding re-interpretation of information already and previously considered. Finally, the presence of several gaps in the knowledge is highlighted.<\/jats:p>","DOI":"10.1177\/2047487319893035","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:01:04Z","timestamp":1576119664000},"page":"181-205","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":193,"title":["Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology"],"prefix":"10.1093","volume":"27","author":[{"given":"Massimo F","family":"Piepoli","sequence":"first","affiliation":[{"name":"Department of Cardiology , Polichirurgico Hospital G Da Saliceto, Italy"},{"name":"Institute of Life Sciences , Sant\u2019Anna School of Advanced Studies, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Abreu","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Cardiologia , Universidade de Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Albus","sequence":"additional","affiliation":[{"name":"Department of Pshychosomatics and Psychotherapy , University of Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ambrosetti","sequence":"additional","affiliation":[{"name":"Department of Cardiac Rehabilitation , Istituti Clinici Scientifici Maugeri IRCCS, Institute of Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Brotons","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute Sant Pau Research Unit , Sardenya Primary Health Care Center, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberico L","family":"Catapano","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Biomolecular Sciences , Universit\u00e0 degli studi di Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Corra","sequence":"additional","affiliation":[{"name":"Department of Cardiac Rehabilitation , Istituti Clinici Scientifici Maugeri IRCCS, Institute of Veruno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cosyns","sequence":"additional","affiliation":[{"name":"Department of Cardiology , Universitair Ziekenhuis Brussel, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christi","family":"Deaton","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care , University of Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Graham","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine , Trinity College Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Hoes","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care , University Medical Center Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja-Lisa","family":"Lochen","sequence":"additional","affiliation":[{"name":"Department of Community Medicine , UiT the Artic University of Norway, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Matrone","sequence":"additional","affiliation":[{"name":"Department of Cardiology , Polichirurgico Hospital G Da Saliceto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Redon","sequence":"additional","affiliation":[{"name":"INCLIVA Research Institute , University of Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences , University of Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvo","family":"Smulders","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care , University Medical Center Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Tiberi","sequence":"additional","affiliation":[{"name":"Azienda Sanitaria Unica Regionale , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"key":"2026080914512051200_bibr1-2047487319893035","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080914512051200_bibr2-2047487319893035","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/ehx628","article-title":"European Society of Cardiology: Cardiovascular Disease Statistics 2017","volume":"39","author":"Timmis","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080914512051200_bibr3-2047487319893035","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.3399\/bjgp16X687973","article-title":"Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study","volume":"67","author":"Crossan","year":"2017","journal-title":"Br J Gen Pract JR Coll Gen Pract"},{"key":"2026080914512051200_bibr4-2047487319893035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/2047487315583798","article-title":"Cost-effectiveness of case-based training for primary care physicians in evidence-based medicine of patients with coronary heart disease","volume":"23","author":"Groot-Jensen","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr5-2047487319893035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/CIRCOUTCOMES.115.001994","article-title":"Health and economic implications of national treatment coverage for cardiovascular disease in India","volume":"8","author":"Basu","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080914512051200_bibr6-2047487319893035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.2018.4242","article-title":"Nontraditional risk factors in cardiovascular disease risk assessment: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"320","author":"Lin","year":"2018","journal-title":"JAMA"},{"key":"2026080914512051200_bibr7-2047487319893035"},{"key":"2026080914512051200_bibr8-2047487319893035","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/jamainternmed.2013.3018","article-title":"Bias in associations of emerging biomarkers with cardiovascular disease","volume":"173","author":"Tzoulaki","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2026080914512051200_bibr9-2047487319893035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S2213-8587(16)30196-6","article-title":"Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis","volume":"4","author":"Natriuretic Peptides Studies Collaboration","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026080914512051200_bibr10-2047487319893035","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacc.2017.05.062","article-title":"High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants","volume":"70","author":"Willeit","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080914512051200_bibr11-2047487319893035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/eurheartj\/ehy653","article-title":"Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies","volume":"40","author":"Pennells","year":"2019","journal-title":"Eur Heart J"},{"issue":"Suppl. 2","key":"2026080914512051200_bibr12-2047487319893035","first-page":"ii1","article-title":"Joint British Societies\u2019 consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","author":"JBS3 Board","year":"2014","journal-title":"Heart Br Cardiac Soc"},{"key":"2026080914512051200_bibr13-2047487319893035","first-page":"866","article-title":"Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score","volume":"99","author":"Dorresteijn","year":"2013","journal-title":"Heart Br Cardiac Soc"},{"key":"2026080914512051200_bibr14-2047487319893035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jacc.2017.06.030","article-title":"Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease","volume":"70","author":"Lindholm","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080914512051200_bibr15-2047487319893035"},{"key":"2026080914512051200_bibr16-2047487319893035"},{"key":"2026080914512051200_bibr17-2047487319893035","doi-asserted-by":"crossref","first-page":"e0210909","DOI":"10.1371\/journal.pone.0210909","article-title":"Evidence of association of circulating epigenetic-sensitive biomarkers with suspected coronary heart disease evaluated by cardiac computed tomography","volume":"14","author":"Infante","year":"2019","journal-title":"PLoS One"},{"key":"2026080914512051200_bibr18-2047487319893035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehv462","article-title":"Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history","volume":"37","author":"Tada","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080914512051200_bibr19-2047487319893035","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting","volume":"135","author":"Natarajan","year":"2017","journal-title":"Circulation"},{"key":"2026080914512051200_bibr20-2047487319893035","first-page":"e004171","article-title":"cardiovascular genetic risk testing for targeting statin therapy in the primary prevention of atherosclerotic cardiovascular disease","volume":"11","author":"Jarmul","year":"2018","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"key":"2026080914512051200_bibr21-2047487319893035","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1177\/2047487317711334","article-title":"Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology","volume":"24","author":"Pogosova","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr22-2047487319893035"},{"key":"2026080914512051200_bibr23-2047487319893035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PSY.0000000000000433","article-title":"Validity of the European Society of Cardiology\u2019s psychosocial screening interview in patients with coronary artery disease \u2013 the THORESCI Study","volume":"79","author":"Van Montfort","year":"2017","journal-title":"Psychosom Med"},{"key":"2026080914512051200_bibr24-2047487319893035","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1161\/CIR.0000000000000536","article-title":"Childhood and adolescent adversity and cardiometabolic outcomes: a scientific statement from the American Heart Association","volume":"137","author":"Suglia","year":"2018","journal-title":"Circulation"},{"key":"2026080914512051200_bibr25-2047487319893035","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"2026080914512051200_bibr26-2047487319893035","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Coronary CT angiography and 5-year risk of myocardial infarction","volume":"379","author":"Newby","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr27-2047487319893035","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00125-019-4886-1","article-title":"Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality","volume":"62","author":"Strelitz","year":"2019","journal-title":"Diabetologia"},{"key":"2026080914512051200_bibr28-2047487319893035","doi-asserted-by":"crossref","first-page":"e3111","DOI":"10.1002\/dmrr.3111","article-title":"Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5-year and longer-term modelled outcomes of the ADDITION-Leicester study","volume":"35","author":"Webb","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"2026080914512051200_bibr29-2047487319893035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"2026080914512051200_bibr30-2047487319893035","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.118.037885","article-title":"Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks","volume":"139","author":"Sattar","year":"2019","journal-title":"Circulation"},{"key":"2026080914512051200_bibr31-2047487319893035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"2026080914512051200_bibr32-2047487319893035","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus","volume":"138","author":"McAllister","year":"2018","journal-title":"Circulation"},{"key":"2026080914512051200_bibr33-2047487319893035","first-page":"1738","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case\u2013control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart Br Cardiac Soc"},{"key":"2026080914512051200_bibr34-2047487319893035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamacardio.2016.0433","article-title":"Seasonal influenza infections and cardiovascular disease mortality","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026080914512051200_bibr35-2047487319893035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr36-2047487319893035","first-page":"CD005050","article-title":"Influenza vaccines for preventing cardiovascular disease","volume":"5","author":"Clar","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080914512051200_bibr37-2047487319893035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/iej.12710","article-title":"Association between apical periodontitis and cardiovascular diseases: a systematic review of the literature","volume":"50","author":"Berlin-Broner","year":"2017","journal-title":"Int Endod J"},{"key":"2026080914512051200_bibr38-2047487319893035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jech-2015-206745","article-title":"Periodontitis is an independent risk indicator for atherosclerotic cardiovascular diseases among 60\u2005174 participants in a large dental school in the Netherlands","volume":"71","author":"Beukers","year":"2017","journal-title":"J Epidemiol Commun Health"},{"key":"2026080914512051200_bibr39-2047487319893035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.amjcard.2016.05.036","article-title":"Relation of periodontitis to risk of cardiovascular and all-cause mortality (from a Danish nationwide cohort study)","volume":"118","author":"Hansen","year":"2016","journal-title":"Am J Cardiol"},{"key":"2026080914512051200_bibr40-2047487319893035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12872-017-0480-y","article-title":"The association between periodontal disease and the risk of myocardial infarction: a pooled analysis of observational studies","volume":"17","author":"Xu","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"2026080914512051200_bibr41-2047487319893035","first-page":"CD009197","article-title":"Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis","volume":"8","author":"Li","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080914512051200_bibr42-2047487319893035","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","article-title":"Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis","volume":"3","author":"Mustian","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026080914512051200_bibr43-2047487319893035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/epirev\/mxx007","article-title":"The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects","volume":"39","author":"Cormie","year":"2017","journal-title":"Epidemiol Rev"},{"key":"2026080914512051200_bibr44-2047487319893035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/2047487318811181","article-title":"Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients","volume":"26","author":"Howden","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr45-2047487319893035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14737159.2017.1283219","article-title":"Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy","volume":"17","author":"Cardinale","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"2026080914512051200_bibr46-2047487319893035","first-page":"119","article-title":"Association between chronic immune-mediated inflammatory diseases and cardiovascular risk","volume":"104","author":"Baena-D\u00edez","year":"2018","journal-title":"Heart Br Cardiac Soc"},{"key":"2026080914512051200_bibr47-2047487319893035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR Recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026080914512051200_bibr48-2047487319893035","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.117.029400","article-title":"Sleep Apnea and cardiovascular disease: lessons from recent trials and need for team science","volume":"136","author":"Drager","year":"2017","journal-title":"Circulation"},{"key":"2026080914512051200_bibr49-2047487319893035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5664\/jcsm.6506","article-title":"Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Kapur","year":"2017","journal-title":"J Clin Sleep Med JCSM: Official Publication of the American Academy of Sleep Medicine"},{"key":"2026080914512051200_bibr50-2047487319893035","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1001\/jama.2015.16303","article-title":"CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis","volume":"314","author":"Bratton","year":"2015","journal-title":"JAMA"},{"key":"2026080914512051200_bibr51-2047487319893035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1557988316630305","article-title":"The association of erectile dysfunction and cardiovascular disease: a systematic critical review","volume":"11","author":"Raheem","year":"2017","journal-title":"Am J Mens Health"},{"key":"2026080914512051200_bibr52-2047487319893035","doi-asserted-by":"crossref","first-page":"e1001372","DOI":"10.1371\/journal.pmed.1001372","article-title":"Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study","volume":"10","author":"Banks","year":"2013","journal-title":"PLoS Med"},{"key":"2026080914512051200_bibr53-2047487319893035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jsxm.2018.01.023","article-title":"British Society for Sexual Medicine Guidelines on the management of erectile dysfunction in men \u2013 2017","volume":"15","author":"Hackett","year":"2018","journal-title":"J Sex Med"},{"key":"2026080914512051200_bibr54-2047487319893035"},{"key":"2026080914512051200_bibr55-2047487319893035","doi-asserted-by":"crossref","first-page":"e020498","DOI":"10.1136\/bmjopen-2017-020498","article-title":"Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1,152,407 subjects","volume":"8","author":"Mahmoud","year":"2018","journal-title":"BMJ Open"},{"key":"2026080914512051200_bibr56-2047487319893035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2017.154","article-title":"Epidemiology of cardiovascular disease in young individuals","volume":"15","author":"Andersson","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2026080914512051200_bibr57-2047487319893035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)","volume":"133","author":"De Ferranti","year":"2016","journal-title":"Circulation"},{"key":"2026080914512051200_bibr58-2047487319893035","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080914512051200_bibr59-2047487319893035","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1712231","article-title":"Relationship between clinic and ambulatory blood-pressure measurements and mortality","volume":"378","author":"Banegas","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr60-2047487319893035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/bjsports-2018-099530","article-title":"Cardiovascular risk profile in Olympic athletes: an unexpected and underestimated risk scenario","volume":"53","author":"D\u2019Ascenzi","year":"2019","journal-title":"Br J Sports Med"},{"key":"2026080914512051200_bibr61-2047487319893035","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.amjcard.2017.02.011","article-title":"Prevalence and management of systemic hypertension in athletes","volume":"119","author":"Caselli","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026080914512051200_bibr62-2047487319893035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12877-017-0626-x","article-title":"Association between traditional cardiovascular risk factors and mortality in the oldest old: untangling the role of frailty","volume":"17","author":"Vaes","year":"2017","journal-title":"BMC Geriatr"},{"key":"2026080914512051200_bibr63-2047487319893035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40985-018-0101-z","article-title":"Screening and treatment of hypertension in older adults: less is more?","volume":"39","author":"Anker","year":"2018","journal-title":"Public Health Rev"},{"key":"2026080914512051200_bibr64-2047487319893035","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force for Diabetes, Pre-diabetes, and Cardiovascular Diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)","author":"Cosentino","journal-title":"Eur Heart J"},{"key":"2026080914512051200_bibr65-2047487319893035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/dme.12885","article-title":"Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials","volume":"33","author":"Seidu","year":"2016","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"2026080914512051200_bibr66-2047487319893035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jacc.2017.10.080","article-title":"Primary prevention with statins in the elderly","volume":"71","author":"Mortensen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080914512051200_bibr67-2047487319893035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","author":"Armitage","year":"2019","journal-title":"Lancet"},{"key":"2026080914512051200_bibr68-2047487319893035"},{"key":"2026080914512051200_bibr69-2047487319893035"},{"key":"2026080914512051200_bibr70-2047487319893035","first-page":"1069","article-title":"Women\u2019s reproductive factors and incident cardiovascular disease in the UK Biobank","volume":"104","author":"Peters","year":"2018","journal-title":"Heart Br Cardiac Soc"},{"key":"2026080914512051200_bibr71-2047487319893035","first-page":"492","article-title":"Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare","volume":"103","author":"Hyun","year":"2017","journal-title":"Heart Br Cardiac Soc"},{"key":"2026080914512051200_bibr72-2047487319893035","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics \u2013 2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"2026080914512051200_bibr73-2047487319893035"},{"key":"2026080914512051200_bibr74-2047487319893035","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Risk Factors","year":"2016","journal-title":"Lancet"},{"key":"2026080914512051200_bibr75-2047487319893035"},{"key":"2026080914512051200_bibr76-2047487319893035","first-page":"e170622","article-title":"Food safety regulatory research needs 2030","volume":"17","author":"Bronzwaer","year":"2019","journal-title":"EFSA J"},{"key":"2026080914512051200_bibr77-2047487319893035"},{"key":"2026080914512051200_bibr78-2047487319893035"},{"key":"2026080914512051200_bibr79-2047487319893035","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.3390\/nu10101542","article-title":"Objective understanding of front-of-package nutrition labels: an international comparative experimental study across 12 countries","volume":"10","author":"Egnell","year":"2018","journal-title":"Nutrients"},{"key":"2026080914512051200_bibr80-2047487319893035"},{"key":"2026080914512051200_bibr81-2047487319893035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S2468-2667(18)30009-4","article-title":"Front-of-pack Nutri-Score labelling in France: an evidence-based policy","volume":"3","author":"Julia","year":"2018","journal-title":"Lancet Public Health"},{"key":"2026080914512051200_bibr82-2047487319893035","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edn. 2018","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA"},{"key":"2026080914512051200_bibr83-2047487319893035","volume-title":"Global action plan on physical activity 2018\u20132030: More active people for a healthier world","author":"World Health Organization"},{"key":"2026080914512051200_bibr84-2047487319893035"},{"key":"2026080914512051200_bibr85-2047487319893035"},{"key":"2026080914512051200_bibr86-2047487319893035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.socscimed.2014.11.051","article-title":"The impact of interventions to promote physical activity in urban green space: a systematic review and recommendations for future research","volume":"124","author":"Hunter","year":"2015","journal-title":"Soc Sci Med"},{"key":"2026080914512051200_bibr87-2047487319893035","volume-title":"WHO Report on the Global Tobacco Epidemic, 2015: Raising Taxes on Tobacco","author":"World Health Organization"},{"key":"2026080914512051200_bibr88-2047487319893035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijcard.2019.07.065","article-title":"Exposure to second hand smoke and 10-year (2002\u20132012) incidence of cardiovascular disease in never smokers: the ATTICA cohort study","volume":"295","author":"Critselis","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026080914512051200_bibr89-2047487319893035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1183\/16000617.0021-2016","article-title":"Tobacco control in Europe: a policy review. European Respiratory Society","volume":"25","author":"Bertollini","year":"2016","journal-title":"Eur Respir Rev"},{"key":"2026080914512051200_bibr90-2047487319893035","doi-asserted-by":"crossref","first-page":"l2287","DOI":"10.1136\/bmj.l2287","article-title":"Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption: quasi-experimental evaluations using interrupted time se ries analysis and in-sample forecast event modelling","volume":"365","author":"Hoffman","year":"2019","journal-title":"BMJ"},{"key":"2026080914512051200_bibr91-2047487319893035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ypmed.2016.10.004","article-title":"Global tobacco prevention and control in relation to a cardiovascular health promotion and disease prevention framework: a narrative review","volume":"93","author":"Carroll","year":"2016","journal-title":"Prev Med"},{"key":"2026080914512051200_bibr92-2047487319893035","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/S2468-2667(17)30045-2","article-title":"Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries an association studies","volume":"2","author":"Gravely","year":"2017","journal-title":"Lancet Public Health"},{"key":"2026080914512051200_bibr93-2047487319893035"},{"key":"2026080914512051200_bibr94-2047487319893035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2015.152","article-title":"Environmental factors in cardiovascular disease","volume":"12","author":"Cosselman","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026080914512051200_bibr95-2047487319893035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/2047487316669415","article-title":"Long-term exposure to traffic-related air pollution and cancer among survivors of myocardial infarction: a 20-year follow-up study","volume":"24","author":"Cohen","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr96-2047487319893035","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1177\/2047487319835984","article-title":"Association of short- and long-term exposure to air pollution with atrial fibrillation","volume":"26","author":"Kwon","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr97-2047487319893035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/CIRCRESAHA.117.306458","article-title":"Environmental determinants of cardiovascular disease","volume":"121","author":"Bhatnagar","year":"2017","journal-title":"Circ Res"},{"key":"2026080914512051200_bibr98-2047487319893035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/2047487318760892","article-title":"Chronic exposure to traffic-related air pollution and cancer incidence among 10,000 patients undergoing percutaneous coronary interventions: a historical prospective study","volume":"25","author":"Cohen","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr99-2047487319893035","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1177\/2047487316639681","article-title":"The telephone lifestyle intervention \u201cHartcoach\u201d has modest impact on coronary risk factors: a randomised multicentre trial","volume":"23","author":"Leemrijse","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr100-2047487319893035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/joim.12802","article-title":"A randomized clinical trial of the effectiveness of a Web-based health behaviour change support system and group lifestyle counselling on body weight loss in overweight and obese subjects: 2-year outcomes","volume":"284","author":"Teeriniemi","year":"2018","journal-title":"J Intern Med"},{"key":"2026080914512051200_bibr101-2047487319893035","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1097\/JCN.0000000000000392","article-title":"Internet-delivered self-management support for improving coronary heart disease and self-management-related outcomes: a systematic review","volume":"32","author":"Palacios","year":"2017","journal-title":"J Cardiovasc Nurs"},{"key":"2026080914512051200_bibr102-2047487319893035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/2047487317695616","article-title":"Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk","volume":"24","author":"Lafeber","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr103-2047487319893035","first-page":"CD012675","article-title":"Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults","volume":"6","author":"Palmer","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080914512051200_bibr104-2047487319893035","first-page":"CD011851","article-title":"Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease","volume":"4","author":"Adler","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080914512051200_bibr105-2047487319893035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/2047487317750913","article-title":"Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: systematic review with meta-synthesis of quantitative and qualitative data","volume":"25","author":"Coorey","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr106-2047487319893035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1177\/2047487319830531","article-title":"Mobile health and implantable cardiac devices: patients\u2019 expectations","volume":"26","author":"Villani","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr107-2047487319893035","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1249\/MSS.0000000000001939","article-title":"Physical activity, all-cause and cardiovascular mortality, and cardiovascular disease","volume":"51","author":"Kraus","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"2026080914512051200_bibr108-2047487319893035","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamainternmed.2015.0533","article-title":"Leisure time physical activity and mortality: a detailed pooled analysis of the dose\u2013response relationship","volume":"175","author":"Arem","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026080914512051200_bibr109-2047487319893035","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1249\/MSS.0000000000001945","article-title":"Physical activity promotion: highlights from the 2018 Physical Activity Guidelines Advisory Committee Systematic Review","volume":"51","author":"King","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"2026080914512051200_bibr110-2047487319893035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/17437199.2014.981777","article-title":"Efficacy of theory-based interventions to promote physical activity. A meta-analysis of randomised controlled trials","volume":"10","author":"Gourlan","year":"2016","journal-title":"Health Psychol Rev"},{"key":"2026080914512051200_bibr111-2047487319893035","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1249\/MSS.0000000000001934","article-title":"High-intensity interval training for cardiometabolic disease prevention","volume":"51","author":"Campbell","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"2026080914512051200_bibr112-2047487319893035","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(16)30370-1","article-title":"Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women","volume":"388","author":"Ekelund","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"2026080914512051200_bibr113-2047487319893035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12529-016-9540-4","article-title":"Systematic review and meta-analysis of peer-led self-management programs for increasing physical activity","volume":"23","author":"Best","year":"2016","journal-title":"Int J Behav Med"},{"key":"2026080914512051200_bibr114-2047487319893035","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jama.2016.12858","article-title":"Effect of wearable technology combined with a lifestyle intervention on long-term weight loss: the IDEA randomized clinical trial","volume":"316","author":"Jakicic","year":"2016","journal-title":"JAMA"},{"key":"2026080914512051200_bibr115-2047487319893035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jpepsy\/jsu108","article-title":"A systematic review: is there an app for that? Translational science of pediatric behavior change for physical activity and dietary interventions","volume":"40","author":"Brannon","year":"2015","journal-title":"J Pediatr Psychol"},{"key":"2026080914512051200_bibr116-2047487319893035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12966-016-0454-y","article-title":"Efficacy of interventions that use apps to improve diet, physical activity and sedentary behaviour: a systematic review","volume":"13","author":"Schoeppe","year":"2016","journal-title":"Int J Behav Nutr Phys Act"},{"key":"2026080914512051200_bibr117-2047487319893035","volume-title":"The Health Consequences of Smoking \u2013 50 Years of Progress: A Report of the Surgeon General","author":"National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health","year":"2014"},{"key":"2026080914512051200_bibr118-2047487319893035","article-title":"JUUL and other stealth vaporisers: hiding the habit from parents and teachers","author":"Ramamurthi","journal-title":"Tob Control"},{"key":"2026080914512051200_bibr119-2047487319893035","first-page":"115","article-title":"Recognition, use and perceptions of JUUL among youth and young adults","volume":"28","author":"Willett","year":"2019","journal-title":"Tob Control"},{"key":"2026080914512051200_bibr120-2047487319893035","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jamapediatrics.2018.1920","article-title":"Prevalence of cannabis use in electronic cigarettes among US youth","volume":"172","author":"Trivers","year":"2018","journal-title":"JAMA Pediatr"},{"key":"2026080914512051200_bibr121-2047487319893035","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/dc17-2222","article-title":"Global diabetes prevention interventions: a systematic review and network meta-analysis of the real-world impact on incidence, weight, and glucose","volume":"41","author":"Galaviz","year":"2018","journal-title":"Diabetes Care"},{"key":"2026080914512051200_bibr122-2047487319893035","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1038\/ncomms4557","article-title":"Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys","volume":"5","author":"Colman","year":"2014","journal-title":"Nat Commun"},{"key":"2026080914512051200_bibr123-2047487319893035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S2213-8587(17)30283-8","article-title":"Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study","volume":"5","author":"Mente","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026080914512051200_bibr124-2047487319893035","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jacc.2015.07.055","article-title":"Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: a prospective cohort study","volume":"66","author":"Li","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080914512051200_bibr125-2047487319893035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000510","article-title":"Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association","volume":"136","author":"Sacks","year":"2017","journal-title":"Circulation"},{"key":"2026080914512051200_bibr126-2047487319893035","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jamainternmed.2016.2417","article-title":"Association of specific dietary fats with total and cause-specific mortality","volume":"176","author":"Wang","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2026080914512051200_bibr127-2047487319893035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3945\/ajcn.116.134460","article-title":"Dairy fat and risk of cardiovascular disease in 3 cohorts of US adults","volume":"104","author":"Chen","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"2026080914512051200_bibr128-2047487319893035","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(17)32253-5","article-title":"Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study","volume":"390","author":"Miller","year":"2017","journal-title":"Lancet"},{"key":"2026080914512051200_bibr129-2047487319893035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3945\/ajcn.116.142521","article-title":"Total red meat intake of \u22650.5 servings\/d does not negatively influence cardiovascular disease risk factors: a systemically searched meta-analysis of randomized controlled trials","volume":"105","author":"O\u2019Connor","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"2026080914512051200_bibr130-2047487319893035","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1161\/CIRCULATIONAHA.118.035225","article-title":"Meta-analysis of randomized controlled trials of red meat consumption in comparison with various comparison diets on cardiovascular risk factors","volume":"139","author":"Guasch-Ferr\u00e9","year":"2019","journal-title":"Circulation"},{"key":"2026080914512051200_bibr131-2047487319893035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.NAJ.0000521973.38717.2e","article-title":"Original research: the effects of red yeast rice supplementation on cholesterol levels in adults","volume":"117","author":"Peng","year":"2017","journal-title":"Am J Nurs"},{"key":"2026080914512051200_bibr132-2047487319893035","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1177\/2047487317715714","article-title":"Variability in strength of red yeast rice supplements purchased from mainstream retailers","volume":"24","author":"Cohen","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr133-2047487319893035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(16)30467-6","article-title":"Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies","volume":"388","author":"Mente","year":"2016","journal-title":"Lancet"},{"key":"2026080914512051200_bibr134-2047487319893035","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrcardio.2015.91","article-title":"Cardiovascular risks and benefits of moderate and heavy alcohol consumption","volume":"12","author":"Fern\u00e1ndez-Sol\u00e0","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026080914512051200_bibr135-2047487319893035","doi-asserted-by":"crossref","first-page":"j909","DOI":"10.1136\/bmj.j909","article-title":"Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records","volume":"356","author":"Bell","year":"2017","journal-title":"BMJ"},{"key":"2026080914512051200_bibr136-2047487319893035","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/add.12828","article-title":"Has the leaning tower of presumed health benefits from \u2018moderate\u2019 alcohol use finally collapsed?","volume":"110","author":"Chikritzhs","year":"2015","journal-title":"Addiction"},{"key":"2026080914512051200_bibr137-2047487319893035","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","article-title":"Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies","volume":"391","author":"Wood","year":"2018","journal-title":"Lancet"},{"key":"2026080914512051200_bibr138-2047487319893035","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr139-2047487319893035","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/jamacardio.2017.3944","article-title":"Clinical efficacy and safety of evolocumab in high-risk patients receiving a statin: secondary analysis of patients with low LDL cholesterol levels and in those already receiving a maximal-potency statin in a randomized clinical trial","volume":"2","author":"Giugliano","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026080914512051200_bibr140-2047487319893035","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr141-2047487319893035","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.2017.9924","article-title":"Updated cost-effectiveness analysis of PCSK9 inhibitors based on the results of the FOURIER trial","volume":"318","author":"Kazi","year":"2017","journal-title":"JAMA"},{"key":"2026080914512051200_bibr142-2047487319893035","doi-asserted-by":"crossref","first-page":"e010007","DOI":"10.1161\/JAHA.118.010007","article-title":"Eligibility, clinical outcomes, and budget impact of PCSK9 inhibitor adoption: the CANHEART PCSK9 Study","volume":"7","author":"Ko","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026080914512051200_bibr143-2047487319893035","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamacardio.2019.1647","article-title":"Updated cost-effectiveness analysis of evolocumab in patients with very high-risk atherosclerotic cardiovascular disease","volume":"4","author":"Fonarow","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026080914512051200_bibr144-2047487319893035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr145-2047487319893035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77,917 individuals","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026080914512051200_bibr146-2047487319893035","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","article-title":"Effects of n-3 fatty acid supplements in diabetes mellitus","volume":"379","author":"The ASCEND Study Collaborative Group","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr147-2047487319893035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine n-3 fatty acids and prevention of cardiovascular disease and cancer","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr148-2047487319893035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"2026080914512051200_bibr149-2047487319893035","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"2026080914512051200_bibr150-2047487319893035","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/dom.13687","article-title":"Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: a retrospective analysis of primary care data, 2010\u20132017","volume":"21","author":"Dennis","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2026080914512051200_bibr151-2047487319893035","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr152-2047487319893035","first-page":"506","article-title":"Hypertension Canada\u2019s 2018 Guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children","volume":"34","author":"Nerenberg","year":"2018","journal-title":"Can J Cardiol"},{"key":"2026080914512051200_bibr153-2047487319893035","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2019.03.501","article-title":"Aspirin for primary prevention of cardiovascular events","volume":"73","author":"Abdelaziz","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080914512051200_bibr154-2047487319893035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/eurheartj\/ehy813","article-title":"Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials","volume":"40","author":"Mahmoud","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080914512051200_bibr155-2047487319893035"},{"key":"2026080914512051200_bibr156-2047487319893035","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/2047487319832393","article-title":"Additional effects of psychological interventions on subjective and objective outcomes compared with exercise-based cardiac rehabilitation alone in patients with cardiovascular disease: a systematic review and meta-analysis","volume":"26","author":"Albus","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr157-2047487319893035","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/PSY.0000000000000626","article-title":"Effectiveness of cognitive behavioral therapy for depression and anxiety in patients with cardiovascular disease: a systematic review and meta-analysis","volume":"80","author":"Reavell","year":"2018","journal-title":"Psychosom Med"},{"key":"2026080914512051200_bibr158-2047487319893035","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.2018.9422","article-title":"Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"2026080914512051200_bibr159-2047487319893035","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr160-2047487319893035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr161-2047487319893035","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr162-2047487319893035","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr163-2047487319893035","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr164-2047487319893035","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr165-2047487319893035","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"2026080914512051200_bibr166-2047487319893035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080914512051200_bibr167-2047487319893035","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/2047487312449597","article-title":"Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the Cardiac Rehabilitation Section of the European Association for Cardiovascular Prevention and Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology","volume":"21","author":"Piepoli","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr168-2047487319893035","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr169-2047487319893035","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/2047487318781359","article-title":"Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey","volume":"25","author":"Kotseva","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr170-2047487319893035","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1093\/eurheartj\/ehy308","article-title":"Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence","volume":"39","author":"Sz\u00e9kely","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080914512051200_bibr171-2047487319893035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/10408363.2018.1460576","article-title":"Novel heart failure biomarkers: why do we fail to exploit their potential?","volume":"55","author":"Piek","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2026080914512051200_bibr172-2047487319893035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/2047487318810019","article-title":"Circulating biomarkers of left ventricular diastolic function and dysfunction: filling the research gap under high pressure","volume":"26","author":"Gajardo","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr173-2047487319893035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ehf2.12071","article-title":"Biomarkers in heart failure: the importance of inconvenient details","volume":"3","author":"Miller","year":"2016","journal-title":"ESC Heart Fail"},{"key":"2026080914512051200_bibr174-2047487319893035","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ejhf.1311","article-title":"Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials","volume":"20","author":"Taylor","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026080914512051200_bibr175-2047487319893035","first-page":"CD003331","article-title":"Exercise-based cardiac rehabilitation for adults with heart failure","volume":"1","author":"Long","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080914512051200_bibr176-2047487319893035"},{"key":"2026080914512051200_bibr177-2047487319893035","first-page":"CD007228","article-title":"Structured telephone support or non-invasive telemonitoring for patients with heart failure","volume":"10","author":"Inglis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080914512051200_bibr178-2047487319893035","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(18)31880-4","article-title":"Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial","volume":"392","author":"Koehler","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"2026080914512051200_bibr179-2047487319893035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080914512051200_bibr180-2047487319893035","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1161\/STR.0000000000000116","article-title":"Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Smith","year":"2017","journal-title":"Stroke"},{"key":"2026080914512051200_bibr181-2047487319893035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s40279-016-0635-5","article-title":"Combined lower limb revascularisation and supervised exercise training for patients with peripheral arterial disease: a systematic review of randomised controlled trials","volume":"47","author":"Men\u00eases","year":"2017","journal-title":"Sports Med Auckl NZ"},{"key":"2026080914512051200_bibr182-2047487319893035","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jcin.2017.01.027","article-title":"Comparative efficacy of endovascular revascularization versus supervised exercise training in patients with intermittent claudication: meta-analysis of randomized controlled trials","volume":"10","author":"Pandey","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080914512051200_bibr183-2047487319893035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"2026080914512051200_bibr184-2047487319893035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/2047487318817910","article-title":"Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: an Australian healthcare perspective","volume":"26","author":"Zomer","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr185-2047487319893035","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease","volume":"67","author":"Bonaca","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080914512051200_bibr186-2047487319893035","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.3399\/bjgp18X697649","article-title":"Delivery and impact of the NHS Health Check in the first 8 years: a systematic review","volume":"68","author":"Martin","year":"2018","journal-title":"Br J Gen Pract"},{"key":"2026080914512051200_bibr187-2047487319893035","doi-asserted-by":"crossref","first-page":"e015375","DOI":"10.1136\/bmjopen-2016-015375","article-title":"Multiple health behaviour change interventions for primary prevention of cardiovascular disease in primary care: systematic review and meta-analysis","volume":"7","author":"Alageel","year":"2017","journal-title":"BMJ Open"},{"key":"2026080914512051200_bibr188-2047487319893035","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1177\/2047487316671181","article-title":"The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies \u2013 the Cardiac Rehabilitation Outcome Study (CROS)","volume":"23","author":"Rauch","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2026080914512051200_bibr189-2047487319893035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/00015385.2017.1361892","article-title":"Economic and social impact of increased cardiac rehabilitation uptake and cardiac telerehabilitation in Belgium \u2013 a cost\u2013benefit analysis","volume":"73","author":"Frederix","year":"2018","journal-title":"Acta Cardiol"},{"key":"2026080914512051200_bibr190-2047487319893035","first-page":"260","article-title":"Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review and meta-analysis","volume":"18","author":"Jin","year":"2019","journal-title":"Eur J Cardiovasc Nurs J Work Group Cardiovasc Nurs Eur Soc Cardiol"},{"key":"2026080914512051200_bibr191-2047487319893035"},{"key":"2026080914512051200_bibr192-2047487319893035","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.jacc.2018.01.004","article-title":"2018 ACC\/AHA Clinical Performance and quality measures for cardiac rehabilitation: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"71","author":"Thomas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080914512051200_bibr193-2047487319893035"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2047487319893035","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2047487319893035","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/27\/2\/181\/34259596\/eurjpc0181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/27\/2\/181\/34259596\/eurjpc0181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T18:51:46Z","timestamp":1786301506000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/27\/2\/181\/5924631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":193,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,29]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1177\/2047487319893035","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1,1]]},"published":{"date-parts":[[2020,1,1]]}}}